More about
Ovarian Cancer
News
April 28, 2020
3 min read
Save
Intratumoral mRNA-2416 monotherapy appears safe for patients with solid tumors
Intratumoral mRNA-2416, a lipid nanoparticle therapeutic agent expressing the wild-type human OX40L, appeared safe among a cohort of patients with locally advanced, recurrent or metastatic solid tumors, according to results of a phase 1/2 first-in-human study presented at the virtual American Association for Cancer Research Annual Meeting.
News
April 11, 2020
1 min read
Save
Cancer researcher becomes The US Oncology Network’s chief scientific officer
News
April 02, 2020
2 min read
Save
Breastfeeding may reduce risk for ovarian cancer
News
March 31, 2020
4 min read
Save
Blood test detects dozens of cancer types, often before symptoms emerge
News
March 12, 2020
1 min read
Save
Phase 3 trial in relapsed ovarian cancer misses primary endpoint
News
February 27, 2020
1 min read
Save
FDA to conduct ‘real-time’ review of Zejula for advanced ovarian cancer
News
January 30, 2020
1 min read
Save
Incorporating belief in miracles into cancer care, other top stories in hematology/oncology
News
January 13, 2020
2 min read
Save
FDA grants priority review to Lynparza as part of ovarian cancer maintenance regimen
News
January 07, 2020
6 min read
Save
No significant link found between powder use, ovarian cancer
News
December 11, 2019
2 min read
Save